Download the gene annotation in CSV format
| KEGG pathway | KEGG ID | KEGG IC |
|---|---|---|
| Melanoma | hsa05218 | 6.56 |
| Bladder cancer | hsa05219 | 7.38 |
| Pancreatic cancer | hsa05212 | 6.56 |
| Endometrial cancer | hsa05213 | 6.81 |
| Colorectal cancer | hsa05210 | 6.52 |
| MAPK signaling pathway | hsa04010 | 4.63 |
| Thyroid cancer | hsa05216 | 7.48 |
| Basal cell carcinoma | hsa05217 | 6.79 |
| Glioma | hsa05214 | 6.66 |
| Prostate cancer | hsa05215 | 6.11 |
| Neurotrophin signaling pathway | hsa04722 | 5.78 |
| Central carbon metabolism in cancer | hsa05230 | 6.7 |
| Herpes simplex infection | hsa05168 | 5.08 |
| Epstein-Barr virus infection | hsa05169 | 4.97 |
| Apoptosis | hsa04210 | 6.23 |
| HTLV-I infection | hsa05166 | 4.59 |
| Hepatitis C | hsa05160 | 5.68 |
| Hepatitis B | hsa05161 | 5.52 |
| Measles | hsa05162 | 5.6 |
| Proteoglycans in cancer | hsa05205 | 5.02 |
| Cell cycle | hsa04110 | 5.68 |
| MicroRNAs in cancer | hsa05206 | 5.38 |
| Pathways in cancer | hsa05200 | 3.98 |
| Viral carcinogenesis | hsa05203 | 5.08 |
| p53 signaling pathway | hsa04115 | 6.56 |
| Non-small cell lung cancer | hsa05223 | 6.88 |
| Small cell lung cancer | hsa05222 | 6.17 |
| Chronic myeloid leukemia | hsa05220 | 6.48 |
| Thyroid hormone signaling pathway | hsa04919 | 5.82 |
| PI3K-Akt signaling pathway | hsa04151 | 4.21 |
| Wnt signaling pathway | hsa04310 | 5.49 |
| Transcriptional misregulation in cancer | hsa05202 | 5.21 |
| Amyotrophic lateral sclerosis (ALS) | hsa05014 | 7.01 |
| Huntington's disease | hsa05016 | 5.17 |
| REACTOME pathway | REACTOME ID | REACTOME IC |
|---|---|---|
| Oncogene Induced Senescence | R-HSA-2559585 | 8.03 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.98 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.15 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.51 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 10.98 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.73 |
| Signaling by NOTCH | R-HSA-157118 | 6.2 |
| Programmed Cell Death | R-HSA-5357801 | 5.65 |
| Cell Cycle | R-HSA-1640170 | 3.89 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.88 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.15 |
| Cellular Senescence | R-HSA-2559583 | 5.7 |
| Generic Transcription Pathway | R-HSA-212436 | 3.86 |
| Gene Expression | R-HSA-74160 | 2.72 |
| Cellular responses to stress | R-HSA-2262752 | 4.56 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.64 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 11.98 |
| Stabilization of p53 | R-HSA-69541 | 7.28 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.15 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.73 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 11.98 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 10.98 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.34 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.49 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.31 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.12 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.08 |
| Apoptosis | R-HSA-109581 | 5.68 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.73 |
| Hemostasis | R-HSA-109582 | 3.98 |
| Signal Transduction | R-HSA-162582 | 1.78 |
| GO term | GO ID | GO IC |
|---|---|---|
| ubiquitin-like protein ligase binding | GO:0044389 | 4.15 |
| purine ribonucleoside triphosphate binding | GO:0035639 | 2.22 |
| cation binding | GO:0043169 | 1.4 |
| enzyme binding | GO:0019899 | 2.27 |
| macromolecular complex binding | GO:0044877 | 2.61 |
| binding | GO:0005488 | 0.18 |
| nucleic acid binding | GO:0003676 | 1.44 |
| DNA binding | GO:0003677 | 1.92 |
| nucleotide binding | GO:0000166 | 1.96 |
| heterocyclic compound binding | GO:1901363 | 1.06 |
| nucleoside phosphate binding | GO:1901265 | 1.96 |
| nucleoside binding | GO:0001882 | 2.21 |
| sequence-specific DNA binding | GO:0043565 | 2.79 |
| sequence-specific double-stranded DNA binding | GO:1990837 | 3.2 |
| transition metal ion binding | GO:0046914 | 2.48 |
| transcription regulatory region DNA binding | GO:0044212 | 3.03 |
| chaperone binding | GO:0051087 | 5.34 |
| receptor tyrosine kinase binding | GO:0030971 | 5.77 |
| ion binding | GO:0043167 | 1.36 |
| identical protein binding | GO:0042802 | 2.63 |
| purine nucleoside binding | GO:0001883 | 2.22 |
| protease binding | GO:0002020 | 5.08 |
| ribonucleoside binding | GO:0032549 | 2.22 |
| purine nucleotide binding | GO:0017076 | 2.19 |
| double-stranded DNA binding | GO:0003690 | 3.09 |
| copper ion binding | GO:0005507 | 5.71 |
| protein tyrosine kinase binding | GO:1990782 | 5.7 |
| RNA polymerase II transcription factor activity, sequence-specific DNA binding | GO:0000981 | 3.29 |
| RNA polymerase II transcription factor binding | GO:0001085 | 5.08 |
| protein heterodimerization activity | GO:0046982 | 3.64 |
| transcription factor binding | GO:0008134 | 3.46 |
| regulatory region nucleic acid binding | GO:0001067 | 3.03 |
| histone acetyltransferase binding | GO:0035035 | 6.41 |
| protein kinase binding | GO:0019901 | 3.44 |
| kinase binding | GO:0019900 | 3.32 |
| protein phosphatase binding | GO:0019903 | 4.93 |
| ubiquitin protein ligase binding | GO:0031625 | 4.17 |
| core promoter binding | GO:0001047 | 4.71 |
| core promoter sequence-specific DNA binding | GO:0001046 | 5.12 |
| receptor binding | GO:0005102 | 2.43 |
| protein self-association | GO:0043621 | 5.93 |
| protein phosphatase 2A binding | GO:0051721 | 6.41 |
| small molecule binding | GO:0036094 | 1.89 |
| metal ion binding | GO:0046872 | 1.41 |
| transcription regulatory region sequence-specific DNA binding | GO:0000976 | 3.24 |
| protein N-terminus binding | GO:0047485 | 5.11 |
| adenyl nucleotide binding | GO:0030554 | 2.4 |
| carbohydrate derivative binding | GO:0097367 | 2.03 |
| organic cyclic compound binding | GO:0097159 | 1.05 |
| nucleic acid binding transcription factor activity | GO:0001071 | 2.65 |
| transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding | GO:0001228 | 3.98 |
| purine ribonucleoside binding | GO:0032550 | 2.22 |
| transcription factor activity, sequence-specific DNA binding | GO:0003700 | 2.65 |
| phosphatase binding | GO:0019902 | 4.63 |
| adenyl ribonucleotide binding | GO:0032559 | 2.41 |
| ATP binding | GO:0005524 | 2.43 |
| protein binding | GO:0005515 | 0.46 |
| regulatory region DNA binding | GO:0000975 | 3.03 |
| purine ribonucleotide binding | GO:0032555 | 2.2 |
| protein dimerization activity | GO:0046983 | 2.72 |
| chromatin binding | GO:0003682 | 3.64 |
| p53 binding | GO:0002039 | 5.53 |
| damaged DNA binding | GO:0003684 | 5.58 |
| ribonucleotide binding | GO:0032553 | 2.19 |
| zinc ion binding | GO:0008270 | 2.66 |